Recent advances in the chemotherapy of malaria. (Q40006543)

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Acute falciparum malaria. Field experience with quinine-pyrimethamine combined therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Imported malaria—A growing world problem

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

A virulent chloroquine-resistant strain of Plasmodium berghei berghei transmitted through Anopheles stephensi

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

2,4,7-Triamino-6-ortho-substituted Arylpteridines. A New Series of Potent Antimalarial Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The Army Malaria Research Program

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Chemotherapy of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

A Method for Screening Antimalarial Compounds in the Mosquito Host

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The action of antimalarial drugs in mosquitoes infected with Plasmodium gallinaceum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

A new criterion for the selection of compounds for curative activity in Plasmodium vivax malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The comparative morphological and physiological effects of various drugs on the sporogonous cycle of Plasmodium gallinaceum in Aedes aegypti

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The sporogonous cycle of Plasmodium vivax in Anopheles mosquitoes as a system for evaluating the prophylactic and curative capabilities of potential antimalarial compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

An Automated Method of Mass Drug Testing Applied to Screening for Antimalarial Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

In vitro development of the mosquito phase of Plasmodium relictum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

In vitro Development of Plasmodium berghei Ookinetes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Cultivation in vitro of Plasmodium gallinaceum oocysts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

CULTIVATION AND PHYSIOLOGY OF ERYTHROCYTIC STAGES OF PLASMODIA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Primary exoerythrocytic schizonts of a mammalian Plasmodium as a source of gametocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Plasmodium berghei: production in vitro of free fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

In vitro Growth of Plasmodium knowlesi and P. falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

A new continuous perfusion technique for the cultivation of malaria parasites in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Studies concerning the mechanism of action of antimalarial drugs. Inhibition of the incorporation of adenosine-8-3H into nucleic acids of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Effects of malarial infection on host microsomal drug-metabolizing enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Malaria--recent progress and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Susceptibility of the Gibbon Hylobates lar to Falciparum Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Falciparum malaria: transmission to the gibbon by Anopheles balabacensis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Susceptibility of a New World Monkey to Plasmodium falciparum from Man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Susceptibility of a New World monkey to Plasmodium malariae from aman

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Plasmodium falciparum infection induced in the black spider monkey, ateles fusciceps, and black howler monkey, alouatta villosa

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The chemotherapy of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials as Antagonists of Purines and Pteroylglutamic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Comparative toxicity of chloroguanide and nitroguanil

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Cardiopulmonary effects of antimalarial drugs. 3. Diaminopyrimidines: trimethoprim (WR 5949) and 5-piperonyl-2,4-diaminopyrimidine (WR 40,070).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The treatment of acute malaria with azacrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Laboratory studies on 3-chloro-9-(4-diethylamino-1-methylbutylamino) acridine, 10-oxide dihydrochloride (CI-423) as an antimalarial compound

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Intramuscular amopyroquin for acute malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Comparative toxicity of chloroquine and bis[(chloro-7″-quinolyl-4″)-amino-2′ propyl]-1,4-piperazine (WR 3863)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

STUDIES ON THE PHARMACOLOGY OF CHLOROQUINE. RECOMMENDATIONS FOR THE TREATMENT OF CHLOROQUINE RETINOPATHY.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Treatment of falciparum malaria caused by strain resistant to quinine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial activity of sulphonamides and a sulphone, singly and in combination with pyrimethamine, against drug resistant and normal strains of laboratory plasmodia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Pathologic physiology and chemotherapy of Plasmodium berghei I. Suppression of parasitemia by sulfones and sulfonamides in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

ANTIMALARIAL EFFECT OF SULPHORTHODIMETHOXINE (FANASIL)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

TREATMENT OF ACUTE FALCIPARUM MALARIA WITH SULPHORTHODIMETHOXINE (FANASIL).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The Evaluation of Sulfonamides, Alone or in Combination with Pyrimethamine, in the Treatment of Multi-Resistant Falciparum Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Sulphormethoxine in chloroquine-resistant falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial effect of diaphenylsulfone and three sulfonamides among semi-immune Africans.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Studies on the chemotherapy of malaria. I. The treatment of overt falciparum malaria with potentiating combinations of pyrimethamine and sulphormethoxine or dapsone in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The chemotherapy of rodent malaria, VII

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Pharmacology of New Antimalarial Drugs Sulfonamides and Trimethoprim

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Treatment of trophozoite-induced Plasmodium knowlesi infection in the rhesus monkey with Trimethoprim and sulfalene

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Clinical trials in Plasmodium falciparum malaria with a long-acting sulphonamide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The drug response of a normal and a multi-resistant strain of P. falciparum to sulphalene

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Enhanced sensitivity of P. falciparum to sulphalene as a consequence of resistance to pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Characteristics and cross-resistance patterns of chloroquine-resistant Plasmodium berghei infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Agranulocytosis Due to Dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The Evaluation of Quinine Sulfate and Diaminodiphenyl Sulfone (DDS) as Suppressive Agents against Sporozoite-Induced Chesson Strain Vivax Malaria *

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Effects of diaphenylsulphone (dapsone) against Plasmodium vivax of South West Pacific origin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. 3,3'-Dinitro (or amino)-4,4'-di (substituted amino) diphenyl sulfones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial sulfilimines and sulfoximines related to diaminodiphenyl sulfoxide and sulfone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial compounds related to diaminodiphenyl sulfone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Treatment of chloroquine-resistant Plasmodium falciparum infections in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Combined Pyrimethamine-Quinine Therapy for Chloroquine-Resistant P. falciparum Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Potentiation of pyrimethamine by sulphadiazine in human malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

A new type of antimalarial drug potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The effect of parasite populations on the curative action of pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Combined therapy for chloroquine-resistant, Plasmodium falciparum infection. Concurrent use of long-acting sulphormethoxine and pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Clinical experience with sulphadiazine and pyrimethamine in the treatment of persons experimentally infected with chloroquine-resistant Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

5-BENZYL-2,4-DIAMINOPYRIMIDINES AS ANTIBACTERIAL AGENTS. I. SYNTHESIS AND ANTIBACTERIAL ACTIVITY IN VITRO.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Treatment of Acute Falciparum Malaria With Sulfalene and Trimethoprim

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Sulfalene and trimethoprim in acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Potential medical problems in personnel returning from Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Medical problems from Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Quinine, pyrimethamine, and sulphorthodimethoxine: Clinical response, plasma levels, and urinary excretion during the initial attack of naturally acquired falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Chloroquine-pyrimethamine-sulfisoxazole therapy of Plasmodium falciparum malaria. An alternative to quinine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Combination Therapy of Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

THE ACTIVITY OF A REPOSITORY FORM OF 4,6-DIAMINO-1(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE AGAINST INFECTIONS WITH PLASMODIUM CYNOMOLGI

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

FURTHER OBSERVATIONS ON THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST THE CHESSON STRAIN OF VIVAX MALARIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Dialysis studies in rats on the long-acting antimalarial CI-501

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The Repository Antimalarial Activities of 4,4'-Diacetyl-Aminodiphenylsulfone and Cycloguanil Pamoate (CI-501) in Monkeys Relative to Local Release Following Parenteral Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST FALCIPARUM MALARIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Cycloguanil pamoate in the treatment and suppression of malaria in the Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

A study of resistance to cycloguanil in Plasmodium gallinaceum in chicks

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Reciprocal Cross Resistance between Cycloguanil Hydrochloride and Pyrimethamine in Plasmodium berghei Infections in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Repository antimalarial drugs: N,N'-diacetyl-4,4'-diaminodiphenylsulphone and related 4-acylaminodiphenylsulphones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

STUDIES ON A DIHYDROTRIAZINE AND A SULFONE, ALONE AND IN COMBINATION, AGAINST PLASMODIUM BERGHEI IN MICE.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Repository drugs. IV. 4',4'''-Sulfonylbisacetanilide (acedapsone, DADDS) and related sulfanilylanilides with prolonged antimalarial and antileprotic action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Repository drugs. V. 4',4'''-[p-phenylenebis(methylidyneimino-p-phenylenesulfonyl)]bisacetanilide (PSBA) and related 4',4'''-[bis(imino-p-phenylenesulfonyl)]bisanilides, a novel class of long-acting antimalarial and antileprotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Repository drugs. VI. 4'-[N-(Aralkylidene-, -Benzylidene-, and -naphthylidene)sulfanilyl]anilides, 4'-[N-[(Dimethylamino)methylene]sulfanilyl]anilides, and related sulfanilylanilides with prolonged antimalarial and antileprotic action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Repository drugs. VII. N-Allylidene-4,4'-sulfonyldianiline and N-(benzylidene- and -1-naphthylmethylene)-N'-methylene-4,4'-sulfonyldianiline polymers with prolonged antimalarial and antileprotic action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Synthetic biologically active polymers. 3. A sulfapyridine-formaldehyde copolymer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Synthetic Biologically Active Polymers. V. 4,4′-Diaminodiphenyl Sulfone-Formaldehyde Copolymer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

An Evaluation of CI-564 against Blood-Induced Chlorguanide-Sensitive and Chlorguanide-Resistant Strains of Vivax Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Evaluation of CI-564, a 1:1 Mixture of Cycloguanil Pamoate (CI-501) and 4,4′-Diacetylaminodiphenylsulfone (CI-556), Against Multiresistant Falciparum Malarias

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

A new repository antimalarial agent, CI-564, used in a field trial in New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

A Field Study on the Effects of a Combination of Cycloguanil Pamoate and Amodiaquine against Malaria in the Rabaul Area of New Guinea *

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Repository drugs. 8. Ester and amide congeners of amodiaquine, hydroxychloroquine, oxychloroquine, primaquine, quinacrine, and related substances as potential long-acting antimalarial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Action of Malarial Antibody in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Resistance of mice and rats to Babesia rodhaini challenge after inoculation with irradiated B. rodhaini infected red cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Plasmodium berghei: Passive transfer of immunity by antisera and cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Immunological studies with simian malarias I. Antigenic variants of Plasmodium cynomolgi bastianellii

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Resistance produced in rats and mice by exposure to irradiated Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Active immunization of mice against Plasmodium berghei. Cross-resistance to a recently isolated strain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Active immunization of rats with a cell-free extract of the erythrocytic parasites of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Active Immunization of Chicks against Plasmodium gallinaceum by Inactivated Homologous Sporozoites and Erythrocytic Parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

CONSIDERATION OF SOME ASPECTS OF HUMAN MALARIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Interferon stimulated by double stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Effect of bacterial endotoxin on the course of Plasmodium berghei infection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Interferon Inducers Protect Mice against Plasmodium berghei Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Anti-malarial Effect of Interferon Inducers at Different Stages of Development of Plasmodium berghei in the Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Role of Interferon in Experimental Mouse Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Effect of polyacrylic acid on experimental malaria and trypanosomiasis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Exogenous Interferon protects Mice against Plasmodium berghei Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Structural modification of febrifugine. Some methylenedioxy analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

THE USE OF SN-10,275 IN THE PROPHYLAXIS AND TREATMENT OF SPOROZOITE-INDUCED VIV AX MALARIA (CHESSON STRAIN)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. IV. New synthesis of .alpha.-(2-pyridyl)- and .alpha.-(2-piperidyl)-2-aryl-4-quinolinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Fluorine-containing 4-quinolinemethanols as antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. Substituted 2-phenyl-4-quinolinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. Analogs of phototoxic 2-phenyl-4-quinolinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. Quinolinemethanol derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial agents. VI. 5-Quinolinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Potential antimalarials. V. 2-p-Chlorophenyl-7-quinolinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. II. 8-Quinolinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Potential antimalarials. IV. Quinoline-.alpha.,.alpha.-dialkylmethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. III. Benzothiazole amino alcohols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Quinoxaline studies. XVII. Potential antimalarials. Some (RS)-.alpha.-(dialkylaminomethyl)-6-chloro-2-quinoxalinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Laboratory evaluation of the photoxic potency of quinolylmethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. II. Alpha-(2-piperidyl)-and alpha-(2-pyridyl)-2-trifluoromethyl-4-quinolinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. II. Quinolinemethanols with decreased phototoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Electronic structure, antimalarial activity, and phototoxicity of selected quinolinemethanol derivatives and analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The photoactivity of quinolinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Synthetic amebicides. X. Antiamebic, antimalarial, and anthelmintic effects of distal hydrazine analogs of azacrine, quinacrine, and 7-{ [3-(octylamino)propyl]amino}benz[c]acridine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial and antischistosomal effects of proximal hydrazine and hydroxylamine analogs of chloroquine and quinacrine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. 4-"proximal" hydrazino derivatives of 7-chloroquinoline

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. Unsaturation in the chloroquine side chain and antimalarial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Quinoline antimalarials. Folded chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. Chloroquine analogs with the 1,2,3,6-tetrahydropyridyl function in the side chain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. 8-chloro-4-(2'-n,n-dibutylamino-1'-hydroxyethyl)benzo[h]-1,6-naphthyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Synthesis of potential antimalarials: primaquine analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Diaminoquinoline antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial Properties of some Guanidine Derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Potential Antimalarial Compounds.1 IX.2 Pyrimidine Derivatives of Urea and Guanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

5-Phenyl-2,4-pentadienamides as Potential Antimalarial Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Derivatives of 5-phenyl-2,4-pentadienoic acid as potential antimalarial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

5,5-Diarylpenta-2,4-dienoic Acid Amides as Potential Antimalarial Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Synthetic trypanocides. I. Substituted 1,2,3,4-tetrahydrocarbazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Potential antimalarial agents. 2-[[(Dialkylamino)alkyl] amino] -3-(2-pyridyl)quinoxalines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Analogs of 3-amino-7-chloro-1,2,4-benzotriazine 1-oxide as antimalarial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

PAM 1392 [2,4-diamino-6-(3,4-dichlorobenzylamino) Quinazoline] as a chemotherapeutic agent: Plasmodium berghei, P. cynomolgi, P. knowlesi, and Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Methotrexate Therapy for Plasmodium vivax Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial activity of tetrahydrohomopteroic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Naphthoquinone Antimalarials. XXIX. 2-Hydroxy-3-(ω-cyclohexylalkyl)-1,4-naphthoquinones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Naphthoquinone Antimalarials. XXX.1 2-Hydroxy-3-[ω-(1-adamantyl)alkyl]-1,4-naphthoquinones2

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Causal Prophylactic Effect of Menoctone (A New Hydroxynaphthoquinone) against Sporozoite-Induced Plasmodium berghei Infection in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Preparation of some sulfonamide and diaminodiphenyl sulfone analogs of 1,4-naphthoquinone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Potential naphthoquinone antimalarials. 2-acylhydrazino-1,4-naphthoquinones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antiprotozoal quinones. IV. 2-Amino-1,4-naphthoquinone imines as potential antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antiprotozoal quinones. II. Synthesis of 4-amino-1,2-naphthoquinones and related compounds as potential antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Pathologic physiology and chemotherapy of Plasmodium berghei. X. Pulmonary edema and naphthoquinones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Pharmacology of naphthoquinones, with special reference to the antimalarial activity of Lapinone (WR 26, 041)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The use of antibiotics in the treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial Activity of Prodigiosin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Inhibition of Rodent Malaria in Mice by Rifampicin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Lincomycin. 8. 4'-Alkyl-1'-demethyl-4'-depropylclindamycins, potent antibacterial and antimalarial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Activity of chlorinated lincomycin analogues against Plasmodium cynomolgi in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

3-piperonylsydnone. A new type of antimalarial agent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial agents. III. Bis[p-(3-sydnonyl)phenyl] sulfone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Structural modification studies of 3-piperonylsydnone. 2. Synthesis of piperonyl-substituted hydantoin, thiohydantoin, thiazolidinedione, rhodanine, imidazolinone, and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Biological activities of some alpha-dithiosemicarbazones.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial activity of guanylhydrazone salts of aromatic ketones. I. Primary search for active substituent patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial Activity of Actinomycin D and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Pathologic physiology and chemotherapy of Plasmodium berghei. IX. Gastric secretion and the influence of 1-aminocyclopentane carboxylic acid (WR 14, 997 or cycloleucine).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Isoquinolines. 1. 3-Amino- and 3-fluoroisoquinoline derivatives as potential antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The syntheses of phenanthrene amino alcohols as antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

New synthesis of antimalarials related to 2-bromo-4,5-dimethoxy-N,N-bis(diethylaminoethyl)aniline. Terminal nitrogen modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarial and antischistosomal effects of alpha,alpha,alpha,alpha',alpha',alpha'-hexachloroxylene derivatives and related halogenated hydrocarbons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Pathologic physiology and chemotherapy of Plasmodium berghei. 8. Liver enzymes and the influence of hexachloroparazylene (WR 17,206).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Methyl benzoquate, a new wide-spectrum coccidiostat for chickens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The antimalarial activity of some quinolone esters

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Chemotherapy of the drug-resistant malarias

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Resistance of P. falciparum to chloroquine in Africa: True or false?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

1 reference

7 January 2021

DRUG RESISTANCE IN PROTOZOA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Determination of molecular weights of dihydrofolate reductases from trypanosomatid flagellates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

ROLE OF P-AMINOBENZOIC ACID IN PLASMODIUM BERGHEI INFECTION IN THE MOUSE.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Pyrimethamine therapy combined with paraaminobenzoic acid-free diet in experimental malaria infection(Plasmodium berghei)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Studies on the nucleic acid synthesis of the agent of malaria in milk-fed mice (Plasmodium berghei)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Acetylation in vitro of para-aminobenzoic acid by unparasitized and Plasmodium berghei parasitized rat reticulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Structure and Properties of Sulfones. I. Electric Moment of 4,4′-Diaminodiphenyl Sulfone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Folate cofactor biosynthesis by Plasmodium berghei. Comparison of folate and dihydrofolate as substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The different effects of antimalarial drugs on Plasmodium lophurae developing intracellularly and extracellularly in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Effect of drugs on the folic and folinic acid contents of erythrocytes infected with malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Chloroquine: Physiological Basis of Drug Resistance in Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The source of purines and pyrimidines in Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Purine and Pyrimidine Synthesis by the Avian Malaria Parasite, Plasmodium lophurae*

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Dihydroorotic acid dehydrogenase: introduction into erythrocyte by the malaria parasite

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The role of N-formyl-methionyl-sRNA in protein biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Incorporation of Radioactive Precursors into DNA and RNA of Plasmodium knowlesi in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Quinacrine: Mechanisms of Antimalarial Action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The influence of antimalarial drugs on nucleic acid synthesis in Plasmodium gallinaceum and Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Base Compositions of DNA from some Malarial Parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

A study of the relationship between the content of adenosine triphosphate in human red cells and the course of falciparum malaria: a new system that may confer protection against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Red Cell ATP and Malaria Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Morphological Effects of Chloroquine on Plasmodium berghei in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Mode of Action of Chloroquine on Plasmodium berghei and P. cynomolgi

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Autophagic vacuoles produced in vitro. II. Studies on the mechanism of formation of autophagic vacuoles produced by chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antibodies to denatured deoxyribonucleic acid in lupus erythematosus serum. V. Mechanism of DNA-anti-DNA inhibition by chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

DNA: Reaction with Chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Reactions of quinine, chloroquine, and quinacrine with DNA and their effects on the DNA and RNA polymerase reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Chloroquine: mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

The structure of the DNA-acridine complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Quinacrine (Atebrin): Mode of Action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Hückel Molecular Orbital Calculations for Some Antimalarial Drugs and Related Molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Phagotrophy and two new structures in the malaria parasite Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Proteolytic enzymes of the erythrocytic forms of roden and simian species of malarial plasmodia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Free Amino-acids of Blood Plasma and Erythrocytes of Normal Ducks and Ducks infected with Malarial Parasite, Plasmodium lophurae

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Free Amino-Acid Production In Vitro by Plasmodium Berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Theory for the Mechanism of Chloroquine Resistance in Rodent Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Some observations on the action of quinine, atebrin, and plasmoquine on Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

1 reference

7 January 2021

The Influence of Three Analogs of Isoleucine on in Vitro Growth and Protein Synthesis of Erythrocytic Forms of Plasmodium Knowlesi

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Amino acid transport and incorporation in red blood cells of normal and Plasmodium knowlesi-infected rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

L-O-Methylthreonine--synthesis and mode of action as an isoleucine antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Malaria Infection ( Plasmodium lophurae ): Changes in Free Amino Acids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Carbon dioxide fixation in malaria (Plasmodium iophurae).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Ultrastructural localisation of NADH- and NADPH-dehydrogenases in the erythrocytic stages of the rodent malaria parasite, Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Potential antimalarial substances. Antimetabolites of pantothenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Antimalarials. Antagonists of pantothenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Coenzyme Q. CXXII. Identification and ubiquinone-8 biosynthesized by Plasmodium knowlesi, P. cynomolgi, and P. berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Coenzyme Q. CVIII. Inhibition of coenzyme Q systems by chloroquine and other antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Effect of the Antimalarial Chloroquine on the Phospholipid Metabolism of Avian Malaria and Heart Tissue *,†

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Effect of Agents Simulating the Abnormalities of the Glucose-6-Phosphate Dehydrogenase-Deficient Red Cell on Plasmodium berghei Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Glucose-6-phosphate-dehydrogenase-deficiency and malaria in Thailand: the comparison of parasite densities and mortality rates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Malarial parasite metabolism: The pentose cycle in Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Carbon dioxide fixation in plasmodia and the effect of some antimalarial drugs on the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Metabolism of Plasmodium berghei. 3. Carbon dioxide fixation and role of pyruvate and dicarboxylic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Carbon dioxide fixation in malaria. II. Plasmodium knowlesi (monkey malaria).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Plasmodium lophurae: [U-14C]-glucose catabolism by free plasmodia and duckling host erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Partial inhibition by mepacrine of the development of sulphonamide resistance in Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

PREVENTION OF THE EMERGENCE OF ANTIBIOTIC-RESISTANT STRAINS OF BACTERIA BY ATABRINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Altered Dihydrofolate Reductase Associated with Drug-Resistance Transfer between Rodent Plasmodia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Altered Dihydrofolate Reductase associated with a Pyrimethamine-resistant Plasmodium berghei berghei produced in a Single Step

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Spontaneous Resistance to Chloroquine in a Strain of Rodent Malaria (Plasmodium berghei yoelii)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Activity of chloroquine against Plasmodium berghei in mice both with and without previous exposure to chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Infectivity of Chloroquine Resistant Plasmodium berghei to Anopheles stephensi enhanced by Chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

COMPLEX FORMATION BETWEEN CHLOROQUINE AND FERRIHAEMIC ACID IN VITRO, AND ITS EFFECT ON THE ANTIMALARIAL ACTION OF CHLOROQUINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

PIGMENT FORMATION AND NUCLEAR DIVISION IN CHLOROQUINE-RESISTANT MALARIA PARASITES (PLASMODIUM BERGHEI, VINCKE AND LIPS, 1948).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Investigations of the possible relation of ferrihemic acid to drug resistance in Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Chloroquine resistance in malaria: a deficiency of chloroquine binding

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Plasmodium falciparum in Owl Monkeys: Drug Resistance and Chloroquine Binding Capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021

Pathologic physiology and chemotherapy of Plasmodium berghei. IV. Influence of chloroquine on oxygen uptake of red blood cells infected with sensitive or resistant strains

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970131-0

7 January 2021